These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 19167613)

  • 1. Inactivation of p53 and amplification of MYCN gene in a terminal lymphoblastic relapse in a chronic lymphocytic leukemia patient.
    Stano-Kozubik K; Malcikova J; Tichy B; Kotaskova J; Borsky M; Hrabcakova V; Francova H; Valaskova I; Bourkova L; Smardova J; Doubek M; Brychtova Y; Pospisilova S; Mayer J; Trbusek M
    Cancer Genet Cytogenet; 2009 Feb; 189(1):53-8. PubMed ID: 19167613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
    Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
    Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.
    Rossi D; Berra E; Cerri M; Deambrogi C; Barbieri C; Franceschetti S; Lunghi M; Conconi A; Paulli M; Matolcsy A; Pasqualucci L; Capello D; Gaidano G
    Haematologica; 2006 Oct; 91(10):1405-9. PubMed ID: 17018394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia.
    Malcikova J; Smardova J; Pekova S; Cejkova S; Kotaskova J; Tichy B; Francova H; Doubek M; Brychtova Y; Janek D; Pospisilova S; Mayer J; Dvorakova D; Trbusek M
    Mol Immunol; 2008 Mar; 45(5):1525-9. PubMed ID: 17920683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
    Slack AD; Chen Z; Ludwig AD; Hicks J; Shohet JM
    Cancer Res; 2007 Mar; 67(6):2448-55. PubMed ID: 17363562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
    Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
    Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant nuclear p53 expression predicts hemizygous 17p (TP53) deletion in chronic lymphocytic leukemia.
    Chang H; Jiang AM; Qi CX
    Am J Clin Pathol; 2010 Jan; 133(1):70-4. PubMed ID: 20023260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
    Scandurra M; Rossi D; Deambrogi C; Rancoita PM; Chigrinova E; Mian M; Cerri M; Rasi S; Sozzi E; Forconi F; Ponzoni M; Moreno SM; Piris MA; Inghirami G; Zucca E; Gattei V; Rinaldi A; Kwee I; Gaidano G; Bertoni F
    Hematol Oncol; 2010 Jun; 28(2):62-7. PubMed ID: 20014148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of IgVH gene somatic hypermutation and interphase cytogenetics in lymphomatous presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Yeung CC; Powers ML; Nguyen TD; Kreisel F; Frater JL; Zehnbauer BA; Burack R; Hassan A
    Int J Surg Pathol; 2011 Oct; 19(5):563-9. PubMed ID: 21536543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
    Gaidano G; Ballerini P; Gong JZ; Inghirami G; Neri A; Newcomb EW; Magrath IT; Knowles DM; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5413-7. PubMed ID: 2052620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.
    Balatti V; Rizzotto L; Miller C; Palamarchuk A; Fadda P; Pandolfo R; Rassenti LZ; Hertlein E; Ruppert AS; Lozanski A; Lozanski G; Kipps TJ; Byrd JC; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2169-74. PubMed ID: 25646413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
    Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
    Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
    Rees-Unwin KS; Faragher R; Unwin RD; Adams J; Brown PJ; Buckle AM; Pettitt A; Hutchinson CV; Johnson SM; Pulford K; Banham AH; Whetton AD; Lucas G; Mason DY; Burthem J
    Br J Haematol; 2010 Feb; 148(4):534-43. PubMed ID: 19961478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clonality analysis and mutation status of IgVH genes in classic Richter's syndrome].
    Mao ZR; Rosenwald A; Zhang SJ; Zhou R; Mueller-Hermelink HK
    Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):364-70. PubMed ID: 19031714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in TP53, cyclin D2, c-Myc, p21WAF1/CIP1 and p27KIP1 expression associated with progression in B-CLL.
    Halina A; Artur P; Barbara MK; Joanna S; Anna D
    Folia Histochem Cytobiol; 2010 Dec; 48(4):534-41. PubMed ID: 21478095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.